Cardiac Arrhythmias Clinical Trial
Official title:
ENHANCED Device Programming to Reduce Therapies and Improve Quality of Life in Implantable Cardioverter Defibrillator Patients: A Prospective, Single-arm Safety Monitoring Study (ENHANCED-ICD Study)
The purpose of this study is to determine whether Enhanced device programming to reduce therapies (i.e. anti tachycardia pacing (ATP) episodes and shocks (both appropriate and inappropriate)) is safe for patients implanted with an Implantable Cardioverter-Defibrillator (ICD). The secondary objective is to examine the impact of Enhanced programming on (i) ATPs and shocks (both appropriate and inappropriate) and (ii) quality of life and distress.
ICD therapy has become the first-line treatment for the prevention of sudden cardiac death
both as primary and secondary prevention due to its proven survival benefits as compared to
anti-arrhythmic drugs. However, ICD therapy is associated with a number of complications and
shocks that may impair patient quality of life and well being but also influence mortality.
Hence, reduction of ICD shocks by means of alternative programming of the device is paramount
for improving patient-centered outcomes and mortality.
The ENHANCED-ICD study will be a prospective, single-arm safety monitoring study. All
patients will receive Enhanced programming. Furthermore, patients will be asked to complete a
set of standardized and validated self-report questionnaires prior to ICD implantation, at
3-, 6-, and 12 months post implantation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05175937 -
REal World Assessment for Patients Implanted With Implantable CardioverTer DefibrIllatOr Using Bluetooth Technology
|
||
Not yet recruiting |
NCT05005143 -
Improved Procedural Workflow For Catheter Ablation Of Paroxysmal AF With High Density Mapping System And Advanced Technology
|
||
Completed |
NCT02684825 -
Detection of Silent Atrial Fibrillation aFter Ischemic StrOke
|
N/A | |
Terminated |
NCT01936480 -
Genetics of QT Response to Moxifloxacin
|
Phase 4 | |
Completed |
NCT01719978 -
Hemodynamic and Electrocardiographic Effects of Hyaluronidase Associated With Local Anaesthetics
|
Phase 4 | |
Completed |
NCT00418314 -
FREEDOM - A Frequent Optimization Study Using the QuickOpt Method
|
N/A | |
Completed |
NCT04361006 -
Cryotherapy Versus Radiofrequency Ablation for Treatment of Para-hisian Accessory Pathways
|
N/A | |
Completed |
NCT02326519 -
Electrical Signal Collection From a 20 Pole Catheter During Routine Cardiac Procedures
|
N/A | |
Completed |
NCT01642537 -
Electroanatomical Mapping of Patients Undergoing Catheter Ablation Procedures Using Rhythmia Mapping System and Catheter
|
N/A | |
Completed |
NCT01509378 -
4P Study: Predictive Quality With Painfree Therapies
|
N/A | |
Completed |
NCT02698670 -
Prospective Registry on User Experience With The Mapping System For Ablation Procedures
|
N/A | |
Recruiting |
NCT01566344 -
Reversal of Cardiomyopathy by Suppression of Frequent Premature Ventricular Complexes
|
N/A | |
Recruiting |
NCT03793998 -
Catheter Ablation of Arrhythmias With High Density Mapping System in the Real World Practice.
|
||
Active, not recruiting |
NCT03110627 -
Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead
|
N/A | |
Recruiting |
NCT05771142 -
Evaluation of an Innovative Smart T-shirt Capable to Monitor ECG Signal and Related Parameters Through the Comparison With a Holter ECG and a Smartwatch
|
||
Not yet recruiting |
NCT02657590 -
Documentation of Cardiac Arrhythmias After Open Heart Surgery
|
N/A | |
Completed |
NCT02080975 -
Determination of Catheter Contact by Evaluation of Microelectrode Near-Field Signals
|
N/A | |
Recruiting |
NCT05724121 -
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
|
||
Completed |
NCT02332096 -
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
|
||
Completed |
NCT01946776 -
Cardiac Arrhythmias in Epilepsy: the CARELINK-study
|
N/A |